semaglutide not being sold anymore Wegovy and Ozempic, both known chemically as semaglutide - Semaglutidecompounded near me being The Semaglutide Shortage is Officially Over: What This Means for Patients and Pharmacies

Semaglutidecompounding The extensive semaglutide shortage that has impacted patients and healthcare providers for a significant period has officially ended.Semaglutide Alternatives That Support Weight Loss - Midi Health On February 21, 2025, the U.S. Food and Drug Administration (FDA) declared that the shortage of semaglutide injection products has been resolvedCompounded Versions Of Ozempic Now Restricted By FDA. This pivotal announcement signifies a major shift in the availability of popular GLP-1 medications, including Ozempic and Wegovy, both of which are chemically known as semaglutide.

For a considerable time, the scarcity of these semaglutide medications led to widespread concern and a surge in the use of compounded versions2025年5月21日—After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drugmust be out of the market by Thursday.. However, the FDA's declaration that the semaglutide shortage has been resolved means these semaglutide injection products from Novo Nordisk are now being continuously shipped and are meeting or exceeding expected U.2025年4月11日—The FDA recently declared an end to the nationwide shortage of their active ingredients,semaglutideand tirzepatide. During the shortage, ...S. demand.2025年10月20日—The global shortage in supply was partly due to a surge in off-label prescriptions of the drugsemaglutide beingissued for weight loss, which ... This means semaglutide is no longer in short supply in its FDA-approved forms. The previous assertion that there was no shortage is now a reality.

The End of Compounded Semaglutide Sales

One of the most significant implications of the resolved semaglutide shortage is the phasing out of compounded versions of the drug. These less expensive, off-brand alternatives were permitted by the FDA during the shortage period as an interim solution.FDA clarifies policies for compounders as national GLP-1 ... However, with the official resolution, compounding pharmacies can no longer make and sell semaglutide injections after a grace period. Federal deadlines have been set, and by specific dates, such as May 22, 2025, and Thursday (referring to the deadline following the FDA's announcement), these compounded versions must be out of the market.

This directive means that many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs.2025年5月27日—After announcing the ends of the shortages, FDA gave the impacted companies a facility-dependent grace period of 60 to 90 days to stopselling... The FDA has taken action, leading to cease-and-desist letters from manufacturers like Novo Nordisk and Eli Lilly2025年2月21日—All semaglutide doses are now being “continuously shipped”to wholesalers and “meeting or exceeding expected U.S. demand,” Novo Nordisk said .... Consequently, the sale of compounded versions of some weight loss medications like Ozempic and Zepbound has been halted or is in the process of being restricted. The era of compounded semaglutide being readily available is drawing to a close, with the FDA’s removal of semaglutide from the drug shortage list in February 2025 being the catalyst.

What This Means for Patients and the Future of GLP-1 Medications

For patients who rely on semaglutide for managing their diabetes or for weight loss, the end of the shortage means greater access to the authentic, FDA-approved medications. The supply of the only real, FDA-approved semaglutide medicines is resolved, ensuring that patients can obtain their prescribed treatments without the uncertainty of shortages. This also implies that the semaglutide shortage has officially ended in the U.Makers of compounded Wegovy, Ozempic threatened by FDA ...S.Semaglutide officially declared no longer on shortage, leading to significant changes in the GLP-1 drug industry.

The FDA's clarification of its policies for compounders, following the end of the semaglutide shortage over, marks a definitive step.2025年7月9日—There is still no generic version of semaglutide on the marketthat's been approved by the Canadian health agency, but the approval process ... While some may inquire about why compounded tirzepatide actions are different or if compounded semaglutide is still available, the general consensus is that the market for these copycat versions is significantly diminishing. Pharmacists do not believe that compounded GLP-1s will disappear completely, but their availability and legality are now under much stricter scrutiny, especially in the absence of an official shortage.

The surge in prescriptions for semaglutide for weight loss was a contributing factor to the global supply issuesDid the FDA ban compounded semaglutide?. Now that the supply chain is stabilizing, the focus shifts back to the approved indications and responsible prescription practices.Semaglutide injections will no longer be sold at ... While some companies may explore alternatives to compounded semaglutide, the primary path forward involves accessing the FDA-approved semaglutide productsNo,not anymore.Semaglutideinjections — which aresoldas Ozempic and Wegovy — arenolonger listed on the FDA website asbeingin shortage. The shortage ....

It's important to note that the FDA has also warned companies that have illegally sold unapproved drugs containing semaglutide, tirzepatide, or retatrutide that are falsely labeled.Our response to serious supply issues of drugs for people ... These actions are a critical part of ensuring patient safety and drug integrity.

In conclusion, the semaglutide shortage has officially ended in the US, bringing relief to manyThe Semaglutide Shortage Is Ending - Sesame. While the landscape of GLP-1 medications is evolving, the resolution of the shortage ensures greater accessibility to semaglutide for those who need it, while also bringing regulated clarity to the market concerning compounded alternatives. The era of the semaglutide shortage is over, and the industry is now navigating a new phase of availability and regulation.These “compounded” versions are going away soon. If that sounds confusing or scary, don't worry. This blog will help you understand what's happening and why.